Increasing subject compliance in pivotal phase III clinical trials of dolutegravir (DTG, S/GSK1349572) in HIV-infected, ART-naïve subjects
Harris, J, Bomar, M, Campbell, MVolume:
15
Language:
english
Journal:
Journal of the International AIDS Society
DOI:
10.7448/IAS.15.6.18241
Date:
November, 2012
File:
PDF, 178 KB
english, 2012